Ozmosi | PSIE-46 Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

PSIE-46

Alternative Names: psie-46, psie46, psie 46
Clinical Status: Inactive
Latest Update: 2021-02-02
Latest Update Note: Clinical Trial Update

Product Description

The core intervention comprises classroom activities grouped in healthy challenges (about diet, physical activity, human body and heart, and emotions management) distributed across the different levels and implemented by the corresponding teachers.  (Sourced from: https://clinicaltrials.gov/ct2/history/NCT02428634?V_6=View)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Unknown

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Foundation for Science, Health and Education, Spain
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

PSIE

N/A

Completed

Body Weight Changes|Acute Respiratory Distress Syndrome

2020-06-01

2021-02-03

Primary Endpoints|Treatments|Trial Status

Recent News Events

Date

Type

Title